title: An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic patients.
authors.forename: Benedikt
authors.initials: B
authors.lastname: Amann
authors.forename: Andrea
authors.initials: A
authors.lastname: Sterr
authors.forename: Eduard
authors.initials: E
authors.lastname: Vieta
authors.forename: Robert
authors.initials: R
authors.lastname: Stampfer
authors.forename: Jörg
authors.initials: J
authors.lastname: Walden
authors.forename: Heinz
authors.initials: H
authors.lastname: Grunze
mesh_terms: D000208:Acute Disease; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010352:Patient Dropouts; D010655:Phenylenediamines / Q000009:adverse effects / Q000627:therapeutic use*; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D002219:Carbamates; D010655:Phenylenediamines; C101866:ezogabine